Research & Clinical Development Solutions
Product Development Lab
Innovation is in your DNA. It's in ours, too.
Product Development: Comprehensive Services
For more than a decade, Alira Health has provided high quality services to clients in acute and non-acute care settings, delivering planning, development, and commercialization solutions including:
Leverage our dedicated, in-house lab
The Alira Health Product Development lab combines scientific expertise with business acumen to guide healthcare innovations from discovery to commercialization. The lab is led by Mitchell Sanders, MS, PhD. Dr. Sanders has spent 30 years working with preclinical animal models and clinical product development in advanced wound care.
Our in-house product development lab provides:
An onsite biosafety level II (BSL-2) facility with an exhaustive library of clinical bacteria isolates
Cell models for inflammation, migration, 3D tumor and apoptosis
Gene expression (qPCR) and immunocytochemistry
Microbiology and biofilm models
Expertise in wound healing and infection prevention
Fluorescent and colorimetric microplate assays
Preclinical animal models
Product Development that humanizes healthcare
Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.
Mitchell Sanders, PhD
Chief Scientific Officer
Our fully dedicated lab team delivers faster execution and better accountability, accelerating commercialization with major milestones to drive better valuations and ROIs.
Product Development News
Music Beats Cancer Hosts Reception at BIO International Convention in San Diego
Music Beats Cancer hosted a reception fostering a networking community for innovators working on promising solutions for cancer.
7e Journée start-up innovantes du dispositif médical
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Event: Innovations In Wound Healing Annual Conference
Join Dr. Mitch Sanders for an exclusive poster session at this event.
Event: SAWC Fall 2021
Join Dr. Sanders at SAWC Fall in Las Vegas, NV.
Infographic: Indication Prioritization and Pre-Commercial Value Assessment
Download our infographic on Indication Prioritization and Pre-Commercial Value Assessment.